The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IGAP | -98.33% | -99.98% | -82.21% | -100% |
| S&P | +15.37% | +82.64% | +12.79% | +327% |
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
No news articles found for GlucoTrack.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | -$9.00K | 10.0% |
| Market Cap | $5.93M | -100.0% |
| Market Cap / Employee | $538.83K | 0.0% |
| Employees | 11 | 83.3% |
| Net Income | -$4,171.00K | 18.0% |
| EBITDA | -$4,300.00K | -32.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $7.87M | 2174.3% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $239.00K | 0.8% |
| Short Term Debt | $3.06M | 51.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -567.22% | -195.3% |
| Return On Invested Capital | -89.78% | -24.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4,688.00K | -12.3% |
| Operating Free Cash Flow | -$4,621.00K | -11.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -642.36 | -0.64 | 0.35 | 0.86 | -100.02% |
| Price to Tangible Book Value | -642.36 | -0.64 | 0.35 | 0.86 | -100.02% |
| Enterprise Value to EBITDA | 0.49 | 2.02 | 1.32 | -0.32 | -93.36% |
| Return on Equity | -541.1% | -1943.3% | -694.3% | -1490.9% | -67.41% |
| Total Debt | $267.00K | $262.00K | $267.00K | $3.30M | 46.25% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
